Gradient aims to enhance the condition of people with pulmonary hypertension.
Gradient Denervation Technologies has raised €14M across 1 funding round from 3 investors, most recently a Series A round in Sep 2023. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-08 | Series A |
| €14M |
| Asabys Partners,Sofinnova Partners,Thuja Capital |
| View deal → |
